No paralogue variants have been mapped to residue 330 for KCNJ2.
| KCNJ2 | GMVEATAMTTQCRSSYLANEILWGHRYEPV>L<FEE-KHYYKVDYSRFHKTYEVPNTPL---- | 355 |
| KCNJ1 | GTVESTSATCQVRTSYVPEEVLWGYRFAPI>V<SKTKEGKYRVDFHNFSKTVEVET-PH---- | 354 |
| KCNJ3 | GIVETTGMTCQARTSYTEDEVLWGHRFFPV>I<SLE-EGFFKVDYSQFHATFEVP-TPP---- | 355 |
| KCNJ4 | GMVEATAMTTQARSSYLASEILWGHRFEPV>V<FEE-KSHYKVDYSRFHKTYEVAGTPC---- | 347 |
| KCNJ5 | GMVEATGMTCQARSSYMDTEVLWGHRFTPV>L<TLE-KGFYEVDYNTFHDTYETN-TPS---- | 361 |
| KCNJ6 | GMVEATGMTCQARSSYITSEILWGYRFTPV>L<TLE-DGFYEVDYNSFHETYETS-TPS---- | 364 |
| KCNJ8 | GVVETTGITTQARTSYIAEEIQWGHRFVSI>V<TEE-EGVYSVDYSKFGNTVKVA-APR---- | 352 |
| KCNJ9 | GMVEATGMTCQARSSYLVDEVLWGHRFTSV>L<TLE-DGFYEVDYASFHETFEVP-TPS---- | 332 |
| KCNJ10 | GTVESTSATCQVRTSYLPEEILWGYEFTPA>I<SLSASGKYIADFSLFDQVVKVAS-PSGLRD | 344 |
| KCNJ11 | GVVETTGITTQARTSYLADEILWGQRFVPI>V<AEE-DGRYSVDYSKFGNTVKVP-TPL---- | 343 |
| KCNJ12 | GMVEATAMTTQARSSYLANEILWGHRFEPV>L<FEE-KNQYKIDYSHFHKTYEVPSTPR---- | 356 |
| KCNJ13 | AMQEGTGEICQRRTSYLPSEIMLHHCFASL>L<TRGSKGEYQIKMENFDKTVPEFPTPL---- | 329 |
| KCNJ14 | GMVEATAMTTQCRSSYLPGELLWGHRFEPV>L<FQR-GSQYEVDYRHFHRTYEVPGTPV---- | 360 |
| KCNJ15 | ATVESTSAVCQSRTSYIPEEIYWGFEFVPV>V<SLSKNGKYVADFSQFEQIRKSP---D---- | 338 |
| KCNJ16 | YTGDSTGTSHQSRSSYVPREILWGHRFNDV>L<EVK-RKYYKVNCLQFEGSVEVY-APF---- | 338 |
| cons | > < |
| Protein | CDS | Disease Classification | Disease | dbSNP links | Effect Prediction |
|---|---|---|---|---|---|
| p.L330F | c.988C>T | Putative Benign | SIFT: Polyphen: |